The effectiveness of intravenous dexmedetomidine on haemodynamic responses during tracheal extubation in patients undergoing craniotomies

Shikha Goyal, Megha Bandil, Ram Pratap Bansal


Background: Dexmedetomidine an α2 agonist reduces heart rate and blood pressure due to sympatholytic activity. The aim of this study was to evaluate the effect of dexmedetomidine on haemodynamic response during endotracheal extubation in patients undergoing craniotomies for intracranial space occupying lesion (ICSOL).

Methods: Sixty patients of ASA grade I and II, age 18-50 years scheduled for craniotomy for nonvascular ICSOL were selected after randomization into 2 groups with 30 patients in each group. Group D and C received an IV infusion of dexmedetomidine 0.5 mg/kg and normal saline 100 ml respectively over 10 min at the time of skin closure in a double-blind manner. Heart rate, systolic and diastolic blood pressure were recorded just before drug administration, 3 and 5 minutes after drug administration, during extubation and at 3, 5, 10 and 15 minutes after extubation. Respiratory rate and oxygen saturation were analyzed at 3, 5, 10 and15 minutes after extubation. Any laryngospasm, bronchospasm, desaturation, respiratory depression, vomiting, hypotension and bradycardia was noted.

Results: Heart rate, systolic and diastolic blood pressure increased during emergence time in both groups (p<0.05) but this increase was more significant in control group than group D. SBP and heart rate were significantly lower in group D from 3 minutes after drug administration to 15 minutes after extubation. DBP was lower in group D during extubation till 15 minutes after extubation (p<0.01). No significant differences were observed in the respect of adverse events between the groups.

Conclusions: Intravenous dexmedetomidine 0.5 mg/kg before extubation is attenuates haemodynamic response during endotracheal extubation in craniotomies.


Craniotomies, Dexmedetomidine, Extubation, Haemodynamic response

Full Text:



Paulissian R, Salem MR, Joseph NJ, Braverman B, Cohen HC, Crystal GJ, et al. Hemodynamic responses to endotracheal extubation after coronary artery bypass grafting. Anesth Analg. 1991;73(1):10-5.

Lowrie A, Johnson PL, Fell D, Robinson SL. Cardiovascular and plasma catecholamine responses at tracheal extubation. Br J Anaesthesia. 1992;68(3):261-3.

Parida S, Badhe A. Emergence hypertension in patients undergoing intracranial surgery. Int J Anesthesiol. 2008;22:1.

Basali A, Mascha EJ, Kalfas I, Schubert A. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiol. 2000;93(1):48-54.

Sharma VB, Prabhakar H, Rath GP, Bithal PK. Comparison of dexmedetomidine and lignocaine on attenuation of airway and pressor responses during tracheal extubation. J Neuroanaesthesiol Crit Care. 2014;1:50-5.

Mikawa K, Nishina K, Maekawa N, Obara H. Attenuation of cardiovascular responses to tracheal extubation; Verapamil versus Diltiazem. Anaesthesia and Analgesia 1996;82(6):1205-10.

Nagatani A, Shibata O, Haseba S, Fukuzaki M, Tomiyasu S, Tsuzaki K, et al. The effect of nitroglycerin ointment on cardiovascular functions in hypertensive patients during emergence from anesthesia. Masui. Japanese J Anesthesiol. 1989;38(10):1312-6.

Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59(2):263-8.

Gertler R, Brown HC, Donald H. Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proceedings. 2001;14(1):13-21.

Alkaya MA, Saraçoglu KT, Pehlivan G, Eti Z, Goguş FY. Effects of esmolol on the prevention of haemodynamic responses to tracheal extubation after craniotomy operations. Turk J Anaesth Reanim. 2014;42(2):86-90.

Virtanen R, Savola JM, Saano V, Nyman L. Characterization of selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonist. Eu J Pharmacol. 1988;150(1-2):9-14.

Scheinin M, Kallio A, Koulu M, Viikari J, Scheinin H. Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers. Br J Clin Pharmacol. 1987;24(4):443-51.

Candiotti KA, Bergese SD, Bokesch PM, Feldman MA, Wisemandle W, Bekker AY. Monitored anaesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicentre trial. Anaesthesia Analgesia. 2010;110(1):47-56.

Keniya VM, Ladi S, Naphade R. Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement. Indian J Anaesth. 2011;55(4):352-7.

Aksu R, Akın A, Bicer C, Esmaoglu A, Tosun Z, Boyaci A. Comparison of the effects of dexmedetomidine versus fentanyl on airway reflexes and hemodynamic responses to tracheal extubation during rhinoplasty: a double-blind, randomized, controlled study. Curr Ther Res. 2009;70 (3):209-20.

Guler G, Akin A, Tosun Z, Eskitascoglu E, Mizrak A, Boyaci A. Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anesthesiol Scand. 2005;49(8):1088-91.

Turan G, Ozgultekin A, Turan C, Dincer E, Yuksel G. Advantageous effects of dexmedetomidine on haemodynamic and recovery responses during extubation for intracranial surgery. Eu J Anaesthesiol. 2008;25(10):816-20.

Jain D, Khan R, Maroof M. "Effect of dexmedetomidine on stress response to extubation." Internet J Anesthesiol. 2008;21:1.

Lawrence CJ, De Lange S. Effects of a single pre‐operative dexmedetomidine dose on isoflurane requirements and peri‐operative haemodynamic stability. Anaesthesia. 1997; 52(8):736-44.

Bindu B, Pasupuleti S, Gowd UP, Gorre V, Murthy RR, Laxmi MB. A double blind, randomized, controlled trial to study the effect of dexmedetomidine on hemodynamic and recovery responses during tracheal extubation. J Anaesthesiol Clin Pharmacol. 2013;29(2):162-7.